Key result
Genetically elevated IL-18 and IFN-γ linked to ~8% higher risk of calcific aortic valvular stenosis.
Why the study?
Although studies have linked several cytokines to calcific aortic valvular stenosis, the causal relationship between circulating cytokines and CAVS remained unclear.
Is there a causal genetic relationship between circulating cytokines and calcific aortic valvular stenosis?
Observational
Is there a causal genetic relationship between circulating cytokines and calcific aortic valvular stenosis?
This Mendelian randomization study suggests potential causal roles for specific cytokines (IL-18, IFN-γ, IL-13, IL-5) in the development of calcific aortic valvular stenosis, providing insights into its inflammatory pathophysiology.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for inflammatory cytokines in CAVS; leaves open causal confirmation and therapeutic targeting.
Available studies have found associations between several cytokines and calcific aortic valvular stenosis (CAVS). To better comprehend the causal link between circulating cytokines and CAVS, we performed a bidirectional Mendelian randomization (MR) study. Genetic variants associated with 41 cytokines were obtained from public genome-wide association study (GWAS), and summary statistics for GWAS of CAVS were obtained from the FinnGen consortium. Forward MR analysis was conducted to determine the impacts of 41 cytokines on CAVS risk and reverse MR analysis was used to determine whether genetic susceptibility to CAVS altered the levels of these cytokines. Inverse-variance weighting (IVW) was implemented as the primary method, and several different sensitivity analyses were used to verify the reliability of the findings. Our results found no significant association between 41 cytokines and CAVS risk. However, increased levels of interleukin-18 (IL-18) (odds ratio [OR] = 1.080, 95% CI: 1.024-1.139) and interferon-gamma (IFN-γ) (OR = 1.157, 95% CI: 1.028-1.302) had suggestive connections with an elevated risk of CAVS, and increased levels of IL-13 (OR = 0.942, 95% CI: 0.890-0.997) and IL-5 (OR = 0.892, 95% CI: 0.804-0.990) had suggestive associations with a reduced risk of CAVS. A reverse MR analysis found that CAVS had a suggestive relationship with a reduced level of platelet-derived growth factor BB (PDGF-BB) (OR = 0.920, 95% CI: 0.853-0.993) and IL-4 (OR = 0.925, 95% CI: 0.856-1.000). Our findings suggest the causal effects of IL-18, IFN-γ, IL-13, and IL-5 on CAVS risk, and genetic predisposition of CAVS may reduce the levels of PDGF-BB and IL-4.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted an observational in Calcific aortic valvular stenosis (CAVS). Circulating cytokines (41 cytokines) was evaluated on Risk of calcific aortic valvular stenosis (OR 1.080, 95% CI 1.024-1.139). Genetically predicted increased levels of IL-18 (OR 1.080; 95% CI 1.024-1.139) and IFN-γ had suggestive associations with an elevated risk of calcific aortic valvular stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: